Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
6 months is a long time to figure out it's all BS, don't ya think? Or maybe it's more like quick pay off that loan! And hurry and fix the other issues we haven't heard about just yet. But yeah, it's probably just a coincidence they are taking action on some of the issues highlighted in the Phase V report right in the middle of the investigation. That would explain why this process is expected to drag on until June. I don't think identifying issues takes very long. But cleaning up and preparing legal defense usually requires some time.
Linda, I know you read this board, so here goes. Why don't you try releasing some news like you did back when the stock went to the high single digits and even the double digits. That strategy seemed to work. The silent strategy has killed the stock, it isn't working, you should have realized this months ago.
So let's go back to what worked. Come on Linda. Don't you remember the payments of $4 stock to Cognate when the share price was at $10 and $12. I know you liked that Linda. Let's try it again.. Please!!
I totally agree with you. Retail longs should be thankful the Phase V report was published. It forced the company to clean up some of the skeletons that were stinking to high heaven. Also created the buying opportunity of a lifetime. What's not to love? These folks were ecstatic to buy in the 6's, 5's, 4's, 3's, 2's and now like crack for an addict they can get their fill in the 1's and soon even lower. Buy buy buy.. Just try to ignore the plop, flush.. You get used to it after awhile.
I'm not making any conclusions. I just find it very interesting how so many jumped to LP's defense and proclaimed that tucking away the IP with an outside source was actually a "good thing" for shareholders (ludicrous BTW). Same same that happens every time someone questions these highly odd and suspect activities. But now that the investigation is in full swing, we are seeing tracks covered and some of these things corrected. I do find it interesting. Very much so. I'm sure some of the folks that have iniated legal proceedings likewise find it very interesting.
Another month in the books with no news. But I thought 2016 was going to be a bustle of activity? ...crickets
But I thought the capital raised in December and February was to launch Phase 2 of the Direct trial?...crickets
But I thought the investigation would wrap up in March. The allegations were all baseless BS, so they should be debunked quickly, right? ...crickets
The only sound around here is the constant flush as more money is sent down the toilet. 1.30's then 1.20's then the next financing. Then the 15 for 1 reverse split.
Like lambs they were led to the slaughter. Like rams and old goats for a sacrifice.
So you think posts that bash the stock bring it down. But what about posts that promote it? Why don't those posts have a positive impact on the stock? There are certainly plenty of them. In fact, there have been more positive than negative. So your theory holds no water, but I'm not sure you will be able to understand.
When you have a trial protocol that the entire study is designed around to achieve specific powering, I don't think you can just randomly lower enrollment and maintain the trial integrity. Maybe exwan or avii can chime in, but I think it would screw up the primary endpoint powering. I've seen several trials over enroll, but not the other way around.
"Long story short, even the last 50 enrolled placebos would have passed their PFS median already if history is any guide."
Okay, and how does this have any bearing whatsoever with reaching full enrollment? Are you saying they are now looking at 2nd IA data?
How can LP's timeline even be considered as a possibility when enrollment isn't complete? Enrollment has to occur before a final readout is possible. But you know that.
Did you notice the multiple times Smith said he feels it is a very low probability the current hold has anything to do with efficacy?
Keep in mind that historically he has had a pretty good finger on the pulse of the company.
Everywhere you look, Flip, more and more arrows pointing to trouble in paradise. And fewer and fewer straws to grasp at. Yet the spin continues. More like a death spiral at this point.
Ever watch Southpark? "And it's gone!!" Sorry, couldn't resist. Are you a MM for this stock? Just curious.
I would have made money shorting this every time you suggested it and I'm sure this time is no different. This is a rare gem of a biotech. These types of opportunities don't come along very often. Wish I would have recognized it much sooner.
Haha, you think it is just happenstance that they have been under a hold for almost 8 months, during which we were told by Linda Powers on multiple occasions that the hold has delayed the trial and that she hoped it would be lifted expeditiously, and now they warn it may never be lifted and you shrug it off as just another boilerplate risk. Hilarious!
From the recent 10k.
"our Phase III trial of DCVax-L is on a partial clinical hold for new screening for enrollment. We do not know what will happen with this partial hold. Although we have over 300 of the planned 348 patients already enrolled in this trial, and they have continued to be treated without interruption, we may not be released from the screening hold and may not be able to complete the planned enrollment in this trial."
Yep, crash and burn. Most here still don't even realize. It's really good news, so don't try to turn it into bad. LMAO
Yes, I will post it if you answer my question about the estimated current value of the shares pre reverse splits. I think it's an important perspective for potential investors to understand. Maybe just calculate what a $10,000 investment in 2006 would look like today if that's easier for you.
Also, please calculate the millions of dollars paid in salary and benefits to the company execs during the past 5 years while the $10,000 withered away into nothing. TIA
Does it bother you at all to so strongly back a penny stock? Rhetorical question. You do know most reputable institutions cannot even touch something like this. It's considered junk. When do you expect the delisting to occur? How about the next reverse split? What about the next dilution? Guess who's calling for 200+ million shares by mid 2017? Yep, the long time bull SOS. Austin and I have been telling you that for years. Who's scoffing now?
Pop quiz. What's the current share price pre the 2007 15 for 1 and 2012 16 for 1 reverse splits?
So you are saying Linda and Les are not aware of anything that may have prompted the new risk disclosure concerning the possibility that the hold may never be lifted and enrollment may not be able to resume for this trial.
We are coming up on 8 months since the trial was put on hold. Recently we were warned that there is a risk the hold may never be lifted and the trial may never be able to resume/complete enrollment. Maybe the next time you talk to Les you could ask what events transpired that made them feel it was time to disclose this risk? Was it part of the "good news" they alluded to last August? Thanks
It sure is taking them a long time to sort out the allegations in the Phase 5 report. You wouldn't think it would take 6 months for the best lawyers to figure out that the report was all pure bunk and totally baseless. It only took our resident experts here about 30 seconds to reach that conclusion, but they didn't even read it or take any of it seriously.
Did you all notice the loan to 3M was paid off recently? Remember that was the genius plan to protect the IP that the die hard bulls thought was such a wonderful structure and in the longs best interest.. Wonder why they felt it was necessary to resolve the loan right in the middle of the investigation? Interesting huh.
I am pleased that Les is starting to take the investigation seriously now instead of non nonchalantly blowing it all off as baloney. I am very happy Woodford forced Linda to do it. Even though it hurt the share price in the short term, it needed to be done. She wouldn't have ever done it on her own without NW. Some people have to learn a lesson the hard way, but hopefully she learned something from Woodford about honesty and transparency during all of this. I bet we would see a 200% or higher increase in the stock overnight if management changes were announced.
Please provide sources as to any collaboration with Adaptive Bio.
Has anyone talked to Les lately?
Remind me what the signicance of 5 months is?
Dan88, I understand your frustration. If all accounts of your stock and call options buys are accurate, you have lost a shipload of money.
With regard to your comments about claims that the company was unaware of any reason for the decline in the stock, keep in mind that the company execs making the statements may well been blinded to the trial data under review at the time.
There are claims that the CRO was hacked by shorts who accessed a confidential trial protocol. It is my opinion they may have similarly accessed efficacy information through other avenues, DMC, principal investigator files, clinics, etc.
In summary, it could have happened separate to the statements made by LP and NW about not being aware of anything untoward. Their statements may have been accurate to the best of their knowledge at the time. One doesn't disprove the possibility of the other.
I hope you find ways to recoup your huge losses here.
I agree. And the manufacturing capacity scenario doesn't make sense as an explanation for the screening halt. Also, they have been "ramping up" manufacturing for years in preparation of commercialization. If they aren't yet ready to manufacture on a larger scale, where did all of that money go? I don't buy it.
I think it is far more likely they received a futility rec at the IA based on analysis of PFS (due to the "havoc of pseudos" and everyone taking longer to event, insignificant difference in treatment vs. control) decided to cease enrollment to save resources, but wanted to continue to treat patients already enrolled to analyze possible benefit to subgroups.
It is possible this info was hacked/discovered by shorts which would explain the major drop in Oct and the lack of short covering in the low to mid $1's ever since. The shorts are smug and confident this is going to $0.00 and they may have inside info. Also explains the recent admission by the company that enrollment may never resume. That's my take anyway.
Dlogic, what are the chances of financial viability for the company if the L trial goes up in flames? Will they have the ability to raise the hundreds of millions necessary to fund large Phase 2 multi center Direct trials targeting many different cancers and simultaneously develop a fully automated closed loop manufacturing system on multiple continents?
What would this magnitude of dilution do to current and prospective shareholders when considering the available/offered terms of financing for the last two capital raises and the current share price?
When looking at the last 15 years of development and clinical testing for the L platform, and the 3 + years already on the books for the Direct Phase 1 safety evaluation, how long are we realistically looking at for Direct to reach commercialization?
Considering the previous 1 for 15 and 1 for 16 reverse splits and the current share price, what would you tell someone looking to invest in the company at this point in time? What would you say to an investor who put down $10,000 pre 2007 who's investment today is worth about $120 and who thought the Phase 3 trial would be completed long ago but has experienced delay after delay while the management team continues to collect hundreds of thousands of dollars per year with no sense of urgency to complete anything?
What would you tell someone looking at a 10 year chart of the stock?
Thanks in advance.
Have you all figured out yet what the last two toxic financings were for? I'll give you a hint, it wasn't for Direct. The next one will happen in a few weeks. Sticking to my prediction of $1 shares with 2 for 1 warrant coverage (if we don't reverse split before then).
Wish Linda would R/S the crap out of this already so that we can move on to the next group of 'recruits'. Rinse and repeat seems to be the historcal MO. I'm hanging around for one reason. To see if NW will peacefully walk away from the 100 + million of shareholder money he lost. Curious to see if has any fight left. Hope we at least see some fireworks..
This may go down as a very ugly blemish on his otherwise stellar track record. GL longs. Sometimes miracles do happen.
It is quite interesting to consider the possibility that the DCVAX trial has already failed and that is the reason for the sharp decrease in the share price over the past few months. I suspect it is possible for such news to leak, or be discovered through other means by certain market participants. If so, maybe certain investors simply "had a bad feeling" about NWBO's stock just like you did about a mystery stock right before CLDX came crashing down.
The biotech sector is a very interesting place to say the least. Maybe someday soon a spotlight will shine a bright light on some of the happenings this year.. One can only hope.
"Or an IA was done and is showing PFS isn't great, yet OS is good, and the company is trying to use iRANO to support why PFS is not good and amend for a co-endpoint to continue the trial. Perhaps the regulators wanted evidence of all imaging and upon review regulators will agree."
Yes, and this fits with both Bosch's pseduo progressives wreck havoc, and LL's everyone is living longer and comparing early DCVAX vs later DCVAX (OS analysis) comments. Again, if the PFS data were a grand slam, why would they need to do all of this?
Mid trial review huh? Interesting. And you say the enrollment hold may never be lifted? Hmm... And you say CLDX went up in flames at their 2nd interim analysis? Hmm.. And you say cldx's stock price plummeted leading up to to the release of news about their trial, almost like there was a leak of the data? Interesting.. And you say that NWBT's stock has been dropping like a rock the last few weeks? Hmm.. And just to be clear they have been conducting a mid trial review? And one of the doctors closest to the action recently said that pseduo progressive patients really wreck havoc on clinical trials? And the principal investigator said that what's happening in the trial really isn't "helping the trial"? Okay, got it.
I think I'll go draw some stick figures, Highwayman..
I wonder what exactly has transpired recently to motivate the language in the 10k that the hold may never be lifted? They just now realized this is a risk after 7 months?
The NDA, if there was one, didn't stop him from financing in October. But he didn't in December or February at much lower prices. Why?
"Who says he's not buying?"
Neil Woodford says so. As of the 13 d/a filed yesterday.
I agree. It is very telling IMO, that certain posters here jumped on him so ferociously when he called for the investigation. They straight up said that he had directed the involvement of Wolfe specifically to undermine NWBO and even implied that he may have been behind the Phase 5 report in order to facilitate a takeover bid.
The lengths that certain folks go to in order to defend NWBO defies common sense and logic and makes me question the reasons for their unwaivering loyalty to LP. NW is by far the best thing that ever happened to NWBO and great effort should be taken by LP to maintain a solid relationship.
It's slightly encouraging to see some positive remarks from the UK whale. But why isn't he buying in the low 1's if he was buying in the double digits. What changed?
I'm not sure what their intent is, but there are some alternate theories.
I'm not the one keeping all DCVAX programs on hold you dip. I understand your frustration, but it is misdirected.
Keep buying more shares Jack. Better prices today than yesterday. They will be better yet tomorrow. One day you will have to reconcile the fact that you had many warnings along the way that went unheeded. GL
I wish we could all see if certain prolific posters here are compensated for what they write. I would encourage everyone to revisit Pearson's article of Seeking Alpha from a while ago. I think he was on to something. Maybe one of NW's investigators will look into it. Maybe not. Maybe it's just a common type of promoting in the investment world..
Does anyone know of a good law firm to contact if one feels they have been intentionally mislead multiple times by the management of a public company? Not talking about ambulance chasers used to manipulate a stock, but rather a firm that has a solid track record of prosecuting scum bag ceo's. TIA
Hello $1.30's. Is the financing at $1.70 smothered in warrants making a little more sense yet? If not, give it a little more time and it will.
But don't let all of the big bad bears here turn your good news into bad and stop you from buying more. Load up!! These prices won't last long.
Quick, someone get a friend of a friend to call Les so he can sprinkle some false hope and positivity on this turd. Just need to wait a few more weeks. Good news is right around the corner..
Hey stop trying to turn this into bad news. It's good news. Great news. They should be receiving a response to their request for AA any day now.